Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer

MLA

Alaa Bawaneh, et al. “Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer.” Cancers, vol. 14, no. 19, Aug. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e6e8db120431877d614c211f1b7e4851&authtype=sso&custid=ns315887.

APA

Alaa Bawaneh, Adam S. Wilson, Nicole Levi, Marissa M. Howard-McNatt, Akiko Chiba, David R. Soto-Pantoja, & Katherine L. Cook. (2022). Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer. Cancers, 14(19).

Chicago

Alaa Bawaneh, Adam S. Wilson, Nicole Levi, Marissa M. Howard-McNatt, Akiko Chiba, David R. Soto-Pantoja, and Katherine L. Cook. 2022. “Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer.” Cancers 14 (19). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e6e8db120431877d614c211f1b7e4851&authtype=sso&custid=ns315887.